30 days of education and awareness programming for patients, caregivers, and the public about cancer immunotherapy and clinical trials
Cancer Research Institute iAtlas Poised to Improve Patient Outcomes by Providing Researchers Greater Access to Genomics Data
Two leading non-profits combine efforts to accelerate cancer immunotherapy for patients globally
First-of-its-kind analysis of the global immuno-oncology clinical landscape from pre-clinical development to regulatory approval provides unprecedented opportunity to advance the field of immuno-oncology to improve patient care.
Fight Colorectal Cancer, Cancer Research Institute announce Cancer Immunology Research article publication discussing CRC immunotherapy advancement
*Immunotherapy results may vary from patient to patient.
Cancer Research Institute | National Headquarters
29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
CRI scientists Dr. Michele Ardolino and Dr. David Raulet showed that Natural Killer cells can help eliminate tumors after checkpoint immunotherapy treatment even in the absence of T cells.
The third installment of the Rational Combinations 360 conference, which will be held in Philadelphia September 13-14, seeks to improve the design and application of combination immunotherapies for patients